Increase in colon cancer among young people
Several years ago, Boston oncologist Dr. Kimmy Ng began noticing an alarming trend in her research. At Dana-Farber Cancer Institute, men in their 20s, 30s and 40s – runners, CrossFitters, lifelong non-smokers – walked through her door. They all looked healthy and strong, but were battling colorectal cancer. Colorectal cancer is a group of diseases […]
Anal cancer mortality rate is high in HIV-infected women
HIV-infected people diagnosed with anal cancer, especially women, have lower survival rates after diagnosis, and survival rates for all people diagnosed with anal cancer have not improved significantly in the past 20 years, says US study announced. Lancet HIV I will report it. Anal cancer is a rare cancer caused by oncogenic strains of human […]
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago
Avastin plus chemotherapy for metastatic colorectal cancer increases over time
Results of a recent study demonstrate that the proportion of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI and Avastin (bevacizumab) increases over time, especially in patients younger than 50 years. . Results of this study were presented at the 2024 ASCO Gastrointestinal Cancer Symposium. FOLFOXIRI is a chemotherapy regimen consisting of […]
Colon cancer deaths are increasing, but overall cancer deaths are decreasing
Share on PinterestExperts say cancer screening is critical to preventing the rise in colorectal cancer deaths.Moe Lindsay Rivera/Stocksy New data from the American Cancer Society shows that deaths from colorectal cancer continue to rise. Meanwhile, overall cancer deaths are decreasing in the United States. Colon cancer is currently the leading cause of cancer death in […]
BMS’ Opdivo regimen shows promise in colorectal cancer clinical trials
BMS’ Opdivo plus Yervoy significantly improved progression-free survival in patients with MSI-H/dMMR metastatic colorectal cancer. Credit: Bristol-Myers Squibb Company. bristol myers squib (BMS) is a Phase III CheckMate-8HW clinical trial combining Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line treatment option for microsatellite-high instability (MSI-H) or mismatch repair deficiency (dMMR). reported promising data. Metastatic colorectal […]
Fruquintinib combination therapy improves quality-adjusted survival in metastatic colorectal cancer
3D illustration of the colon – Stock.adobe.com The combination of fruquintinib (Fruzakura) and optimal supportive care led to Results from an in-phase post-hoc analysis show that quality-adjusted time to absence of symptoms of disease or toxicity increased when compared with placebo and optimal supportive care in previously treated patients with metastatic colorectal cancer (CRC). The […]
Research Shows Increased Risk of Cancer in Relatives of People with Leukemia
Relatives of patients with myelodysplastic tumors (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) are at increased risk of cancer, according to a study published in the February issue of the journal It was revealed. cancer epidemiology. Nikolaj Juul Nitschke and colleagues at Copenhagen University Hospital in Denmark used linked data from the […]
New PET tracer accurately detects common cancer mutations and enables targeted treatment
New PET imaging tracers have been proven to safely and effectively detect common cancer gene mutations, which are important molecular markers for tumor-targeted therapies. Identifying this mutation early allows doctors to tailor treatment plans to patients to achieve the best results. The study was published in the December issue of the journal. nuclear medicine journal. […]
Standard treatment outperforms initial surgery for rectal cancer
Top line: Patients with locally advanced disease rectal cancer Standard preoperative chemoradiotherapy followed by surgery is better than primary surgery and postoperative chemoradiotherapy, with better disease-free survival and lower recurrence rates. methodology: The standard treatment for locally advanced rectal cancer is chemoradiotherapy followed by surgery, which is known to reduce the chance of local recurrence. […]